🇺🇸 FDA
Patent

US 11246926

Polynucleotides encoding anti-C1s antibodies

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 11246926 (Polynucleotides encoding anti-C1s antibodies) held by Bioverativ USA Inc. expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Bioverativ USA Inc.
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/3955, A61P